Combinatorial roles for histamine H 1-H 2 and H 3-H 4 receptors in autoimmune inflammatory disease of the central nervous system

European Journal of Immunology

Volumn 42, Issue 6, 2012, Pages 1536-1546

  Saligrama, Naresha ^a   Noubade, Rajkumar ^a   Case, Laure K ^a   del Rio, Roxana ^a   Teuscher, Cory ^a,b,c  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF VERMONT   (United States)

^c University of Houston   (United States)

Author keywords

Disease modifying therapy; Experimental allergic encephalomyelitis; G protein coupled receptors; Histamine; Multiple sclerosis

Indexed keywords

GAMMA INTERFERON; HISTAMINE H1 RECEPTOR; HISTAMINE H2 RECEPTOR; HISTAMINE H3 RECEPTOR; HISTAMINE H4 RECEPTOR; INTERLEUKIN 17; INTERLEUKIN 4;

ALLERGIC ENCEPHALITIS; ANIMAL EXPERIMENT; ARTICLE; AUTOIMMUNE DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; EFFECTOR CELL; HEMATOPOIESIS; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; POLARIZATION; PRIORITY JOURNAL; SPLEEN CELL; TH1 CELL; TH17 CELL; UPREGULATION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL POLARITY; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MULTIPLE SCLEROSIS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, HISTAMINE; RECEPTORS, HISTAMINE H1; RECEPTORS, HISTAMINE H2; RECEPTORS, HISTAMINE H3;

EID: 84862130852     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201141859     Document Type: Article

References (56)

1. Greenstein, J. I., Current concepts of the cellular and molecular pathophysiology of multiple sclerosis. Dev. Neurobiol. 2007. 67: 1248-1265.
2. Fletcher, J. M., Lalor, S. J., Sweeney, C. M., Tubridy, N. and Mills, K. H., T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin. Exp. Immunol. 2010. 162: 1-11.
3. Parsons, M. E. and Ganellin, C. R., Histamine and its receptors. Br. J. Pharmacol. 2006. 147(Suppl 1): S127-S135.
4. Akdis, C. A. and Simons, F. E., Histamine receptors are hot in immunopharmacology. Eur. J. Pharmacol. 2006. 533: 69-76.
5. Metcalfe, D. D., Baram, D. and Mekori, Y. A., Mast cells. Physiol. Rev. 1997. 77: 1033-1079.
6. Taguchi, Y., Tsuyama, K., Watanabe, T., Wada, H. and Kitamura, Y., Increase in histidine decarboxylase activity in skin of genetically mast-cell-deficient W/Wv mice after application of phorbol 12-myristate 13-acetate: evidence for the presence of histamine-producing cells without basophilic granules. Proc. Natl. Acad. Sci. USA 1982. 79: 6837-6841.
7. Aoi, R., Nakashima, I., Kitamura, Y., Asai, H. and Nakano, K., Histamine synthesis by mouse T lymphocytes through induced histidine decarboxylase. Immunology 1989. 66: 219-223.
8. Takamatsu, S., Nakashima, I. and Nakano, K., Modulation of endotoxin-induced histamine synthesis by cytokines in mouse bone marrow-derived macrophages. J. Immunol. 1996. 156: 778-785.
9. Shiraishi, M., Hirasawa, N., Oikawa, S., Kobayashi, Y. and Ohuchi, K., Analysis of histamine-producing cells at the late phase of allergic inflammation in rats. Immunology 2000. 99: 600-606.
10. Ghosh, A. K., Hirasawa, N., Ohtsu, H., Watanabe, T. and Ohuchi, K., Defective angiogenesis in the inflammatory granulation tissue in histidine decarboxylase-deficient mice but not in mast cell-deficient mice. J. Exp. Med. 2002. 195: 973-982.
11. Yokoyama, M., Yokoyama, A., Mori, S., Takahashi, H. K., Yoshino, T., Watanabe, T., Ohtsu, H. et al., Inducible histamine protects mice from P. acnes-primed and LPS-induced hepatitis through H2-receptor stimulation. Gastroenterology 2004. 127: 892-902.
12. Tanaka, S., Deai, K., Konomi, A., Takahashi, K., Yamane, H., Sugimoto, Y. and Ichikawa, A., Expression of L-histidine decarboxylase in granules of elicited mouse polymorphonuclear leukocytes. Eur. J. Immunol. 2004. 34: 1472-1482.
13. Yang, X. D., Ai, W., Asfaha, S., Bhagat, G., Friedman, R. A., Jin, G., Park, H. et al., Histamine deficiency promotes inflammation-associated carcinogenesis through reduced myeloid maturation and accumulation of CD11b+Ly6G+ immature myeloid cells. Nat. Med. 2011. 17: 87-95.
14. Hill, S. J., Ganellin, C. R., Timmerman, H., Schwartz, J. C., Shankley, N. P., Young, J. M., Schunack, W. et al., International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacol. Rev. 1997. 49: 253-278.
15. Leurs, R., Smit, M. J. and Timmerman, H., Molecular pharmacological aspects of histamine receptors. Pharmacol. Ther. 1995. 66: 413-463.
16. Liu, C., Ma, X., Jiang, X., Wilson, S. J., Hofstra, C. L., Blevitt, J., Pyati, J. et al., Cloning and pharmacological characterization of a fourth histamine receptor (H(4)) expressed in bone marrow. Mol. Pharmacol. 2001. 59: 420-426.
17. Lethbridge, N. L. and Chazot, P. L., Immunological identification of the mouse H4 histamine receptor on spinal cord motor neurons using a novel anti-mouse H4R antibody. Inflamm. Res. 2010. 59(Suppl 2): S197-S198.
18. Teuscher, C., Subramanian, M., Noubade, R., Gao, J. F., Offner, H., Zachary, J. F. and Blankenhorn, E. P., Central histamine H3 receptor signaling negatively regulates susceptibility to autoimmune inflammatory disease of the CNS. Proc. Natl. Acad. Sci. USA 2007. 104: 10146-10151.
19. Jadidi-Niaragh, F. and Mirshafiey, A., Histamine and histamine receptors in pathogenesis and treatment of multiple sclerosis. Neuropharmacology 2010. 59: 180-189.
20. El Behi, M., Dubucquoi, S., Lefranc, D., Zephir, H., De Seze, J., Vermersch, P. and Prin, L., New insights into cell responses involved in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol. Lett. 2005. 96: 11-26.
21. Theoharides, T. C. and Cochrane, D. E., Critical role of mast cells in inflammatory diseases and the effect of acute stress. J. Neuroimmunol. 2004. 146: 1-12.
22. Alonso, A., Jick, S. S. and Hernan, M. A., Allergy, histamine 1 receptor blockers, and the risk of multiple sclerosis. Neurology 2006. 66: 572-575.
23. Logothetis, L., Mylonas, I. A., Baloyannis, S., Pashalidou, M., Orologas, A., Zafeiropoulos, A., Kosta, V. et al., A pilot, open label, clinical trial using hydroxyzine in multiple sclerosis. Int. J. Immunopathol. Pharmacol. 2005. 18: 771-778.
24. Lock, C., Hermans, G., Pedotti, R., Brendolan, A., Schadt, E., Garren, H., Langer-Gould, A. et al., Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 2002. 8: 500-508.
25. Bebo, B. F., Jr., Yong, T., Orr, E. L. and Linthicum, D. S., Hypothesis: a possible role for mast cells and their inflammatory mediators in the pathogenesis of autoimmune encephalomyelitis. J. Neurosci. Res. 1996. 45: 340-348.
26. Gregory, G. D., Robbie-Ryan, M., Secor, V. H., Sabatino, J. J., Jr. and Brown, M. A., Mast cells are required for optimal autoreactive T cell responses in a murine model of multiple sclerosis. Eur. J. Immunol. 2005. 35: 3478-3486.
27. Ma, R. Z., Gao, J., Meeker, N. D., Fillmore, P. D., Tung, K. S., Watanabe, T., Zachary, J. F. et al., Identification of Bphs, an autoimmune disease locus, as histamine receptor H1. Science 2002. 297: 620-623.
28. Pedotti, R., De Voss, J. J., Steinman, L. and Galli, S. J., Involvement of both 'allergic' and 'autoimmune' mechanisms in EAE, MS and other autoimmune diseases. Trends Immunol. 2003. 24: 479-484.
29. Emerson, M. R., Orentas, D. M., Lynch, S. G. and LeVine, S. M., Activation of histamine H2 receptors ameliorates experimental allergic encephalomyelitis. Neuroreport 2002. 13: 1407-1410.
30. Musio, S., Gallo, B., Scabeni, S., Lapilla, M., Poliani, P. L., Matarese, G., Ohtsu, H. et al., A key regulatory role for histamine in experimental autoimmune encephalomyelitis: disease exacerbation in histidine decarboxylase-deficient mice. J. Immunol. 2006. 176: 17-26.
31. Noubade, R., Milligan, G., Zachary, J. F., Blankenhorn, E. P., del Rio, R., Rincon, M. and Teuscher, C., Histamine receptor H1 is required for TCR-mediated p38 MAPK activation and optimal IFN-gamma production in mice. J. Clin. Invest. 2007. 117: 3507-3518.
32. Teuscher, C., Poynter, M. E., Offner, H., Zamora, A., Watanabe, T., Fillmore, P. D., Zachary, J. F. et al., Attenuation of Th1 effector cell responses and susceptibility to experimental allergic encephalomyelitis in histamine H2 receptor knockout mice is due to dysregulation of cytokine production by antigen-presenting cells. Am. J. Pathol. 2004. 164: 883-892.
33. Lu, C., Diehl, S. A., Noubade, R., Ledoux, J., Nelson, M. T., Spach, K., Zachary, J. F. et al., Endothelial histamine H1 receptor signaling reduces blood-brain barrier permeability and susceptibility to autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 2010. 107: 18967-18972.
34. Del Rio, R., Noubade, R., Saligrama, N., Wall, E. H., Krementsov, D. N., Poynter, M. E., Zachary, J. F. et al., Histamine H4 receptor optimizes T regulatory cell frequency and facilitates anti-inflammatory responses within the central nervous system. J. Immunol. 2012. 188: 541-547.
35. Goodin, D. S., Frohman, E. M., Garmany, G. P., Jr., Halper, J., Likosky, W. H., Lublin, F. D., Silberberg, D. H. et al., Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines. Neurology 2002. 58: 169-178.
36. Leurs, R., Vischer, H. F., Wijtmans, M. and de Esch, I. J., En route to new blockbuster anti-histamines: surveying the offspring of the expanding histamine receptor family. Trends Pharmacol. Sci. 2011. 32: 250-257.
37. Butterfield, R. J., Sudweeks, J. D., Blankenhorn, E. P., Korngold, R., Marini, J. C., Todd, J. A., Roper, R. J. et al., New genetic loci that control susceptibility and symptoms of experimental allergic encephalomyelitis in inbred mice. J. Immunol. 1998. 161: 1860-1867.
38. Teuscher, C., Noubade, R., Spach, K., McElvany, B., Bunn, J. Y., Fillmore, P. D., Zachary, J. F. et al., Evidence that the Y chromosome influences autoimmune disease in male and female mice. Proc. Natl. Acad. Sci. USA 2006. 103: 8024-8029.
39. Schneider, E., Bertron, A. F. and Dy, M., Modulation of hematopoiesis through histamine receptor signaling. Front Biosci. (Schol Ed) 2011. 3: 467-473.
40. Horvath, Z., Pallinger, E., Horvath, G., Jelinek, I., Falus, A. and Buzas, E. I., Histamine H1 and H2 receptors but not H4 receptors are upregulated during bone marrow regeneration. Cell Immunol. 2006. 244: 110-115.
41. Horvath, Z., Pallinger, E., Horvath, G., Jelinek, I., Veszely, G., Furesz, J., Falus, A. et al., Extramedullary hematopoiesis is dysregulated in histamine-free histidine decarboxylase knockout (HDC-/-) mice. Inflamm. Res. 2010. 59: 429-436.
42. Jutel, M., Watanabe, T., Klunker, S., Akdis, M., Thomet, O. A., Malolepszy, J., Zak-Nejmark, T. et al., Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature 2001. 413: 420-425.
43. Prat, A. and Antel, J., Pathogenesis of multiple sclerosis. Curr. Opin. Neurol. 2005. 18: 225-230.
44. Zampeli, E. and Tiligada, E., The role of histamine H4 receptor in immune and inflammatory disorders. Br. J. Pharmacol. 2009. 157: 24-33.
45. Schneider, E., Rolli-Derkinderen, M., Arock, M. and Dy, M., Trends in histamine research: new functions during immune responses and hematopoiesis. Trends Immunol. 2002. 23: 255-263.
46. Huang, J. F. and Thurmond, R. L., The new biology of histamine receptors. Curr. Allergy Asthma Rep. 2008. 8: 21-27.
47. Lapilla, M., Gallo, B., Martinello, M., Procaccini, C., Costanza, M., Musio, S., Rossi, B. et al., Histamine regulates autoreactive T cell activation and adhesiveness in inflamed brain microcirculation. J. Leukoc. Biol. 2011. 89: 259-267.
48. Gillson, G., Wright, J. V., DeLack, E. and Ballasiotes, G., Transdermal histamine in multiple sclerosis: part one - clinical experience. Altern. Med. Rev. 1999. 4: 424-428.
49. Gillson, G., Wright, J. V., DeLack, E. and Ballasiotes, G., Transdermal histamine in multiple sclerosis, part two: a proposed theoretical basis for its use. Altern. Med. Rev. 2000. 5: 224-248.
50. Nielsen, H. J. and Hammer, J. H., Possible role of histamine in pathogenesis of autoimmune diseases: implications for immunotherapy with histamine-2 receptor antagonists. Med. Hypotheses 1992. 39: 349-355.
51. Banu, Y. and Watanabe, T., Augmentation of antigen receptor-mediated responses by histamine H1 receptor signaling. J. Exp. Med. 1999. 189: 673-682.
52. Kobayashi, T., Tonai, S., Ishihara, Y., Koga, R., Okabe, S. and Watanabe, T., Abnormal functional and morphological regulation of the gastric mucosa in histamine H2 receptor-deficient mice. J. Clin. Invest. 2000. 105: 1741-1749.
53. Toyota, H., Dugovic, C., Koehl, M., Laposky, A. D., Weber, C., Ngo, K., Wu, Y. et al., Behavioral characterization of mice lacking histamine H(3) receptors. Mol. Pharmacol. 2002. 62: 389-397.
54. Hofstra, C. L., Desai, P. J., Thurmond, R. L. and Fung-Leung, W. P., Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells. J. Pharmacol. Exp. Ther. 2003. 305: 1212-1221.
55. Teuscher, C., Bunn, J. Y., Fillmore, P. D., Butterfield, R. J., Zachary, J. F. and Blankenhorn, E. P., Gender, age, and season at immunization uniquely influence the genetic control of susceptibility to histopathological lesions and clinical signs of experimental allergic encephalomyelitis: implications for the genetics of multiple sclerosis. Am. J. Pathol. 2004. 165: 1593-1602.
56. Noubade, R., del Rio, R., McElvany, B., Zachary, J. F., Millward, J. M., Wagner, D. D., Offner, H. et al., von-Willebrand factor influences blood brain barrier permeability and brain inflammation in experimental allergic encephalomyelitis. Am. J. Pathol. 2008. 173: 892-900.